OTC · WWHC
W World Corp.
Financial Services · Shell Companies
$0.80
Down-$0.20 (-20.00%)
Updated Aug 17, 2026, 2:44 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 80.24M
- P/E ratio
- -8,683.79
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 200
- Avg. volume
- 3
Price performance
WWHC price history
1M range · 0 trading sessions · Daily adjusted prices
WWHC does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest WWHC news
The latest Smart Investors Daily articles mentioning WWHC.
Stock researchCompany · Overview
WWHC research
Overview
Company profile and research snapshot.
Company profile
W World Corp., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent, which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in North Las Vegas, Nevada.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
